Hypersecretion of OmlA antigen in Corynebacterium glutamicum through high-throughput based development process

Appl Microbiol Biotechnol. 2022 Apr;106(8):2953-2967. doi: 10.1007/s00253-022-11918-x. Epub 2022 Apr 18.

Abstract

Outer membrane lipoprotein A (OmlA) is a vaccine antigen against porcine contagious pleuropneumonia (PCP), a disease severely affecting the swine industry. Here, we aimed to systematically potentiate the secretory production of OmlA in Corynebacterium glutamicum (C. glutamicum), a widely used microorganism in the food industry, by establishing a holistic development process based on our high-throughput culture platform. The expression patterns, expression element combinations, medium composition, and induction conditions were comprehensively screened or optimized in microwell plates (MWPs), followed by fermentation parameter optimization in a 4 × 1 L parallel fermentation system (CUBER4). An unprecedented yield of 1.01 g/L OmlA was ultimately achieved in a 5-L bioreactor following the scaling-up strategy of fixed oxygen mass transfer coefficient (kLa), and the produced OmlA antigen showed well-protective immunity against Actinobacillus pleuropneumoniae challenge. This result provides a rapid and reliable pipeline to achieve the hyper-production of OmlA, and possibly other recombinant vaccines, in C. glutamicum. KEY POINTS: • Established a holistic development process and applied it to potentiate the secretion of OmlA. • The secretion of OmlA reached an unprecedented yield of 1.01 g/L. • The recombinant OmlA antigen induced efficient protective immunity.

Keywords: Bicistron; Corynebacterium glutamicum; High-throughput culture; Outer membrane lipoprotein A; Process development.

MeSH terms

  • Actinobacillus pleuropneumoniae*
  • Animals
  • Bioreactors
  • Corynebacterium glutamicum* / genetics
  • Corynebacterium glutamicum* / metabolism
  • Fermentation
  • Lipoprotein(a) / metabolism
  • Swine

Substances

  • Lipoprotein(a)